Gr Sarantis (SAR) Q1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 TU earnings summary
23 Apr, 2026Executive summary
Net sales for Q1 2026 rose 3.7% year-over-year to €147.1m, driven by a favorable sales mix and seasonal factors, notably suncare and Easter timing.
EBITDA increased 19.9% to €23.3m, with margin expansion to 15.8%, reflecting operational efficiency and cost discipline.
EBIT grew 18.2% to €17.5m, with margin up to 11.9%, supported by higher-margin categories and ongoing cost efficiencies.
Strategic initiatives advanced, including SAP S/4HANA rollout in new countries and supply chain investments yielding benefits.
International expansion continued, with focus on the Carroten brand and US market.
Financial highlights
Net sales reached €147.1m in Q1 2026, up from €141.9m in Q1 2025.
EBITDA rose to €23.3m from €19.4m, with margin up 214bps to 15.8%.
EBIT increased to €17.5m from €14.8m, with margin up 147bps to 11.9%.
Outlook and guidance
Management remains confident in delivering profitable growth for 2026, citing disciplined execution and ongoing strategic investments.
Continued vigilance to geopolitical and macroeconomic risks is emphasized.
Latest events from Gr Sarantis
- EBITDA and net income surged in 2025, led by branded and beauty growth and global expansion.SAR
H2 202512 Mar 2026 - Record H1 sales and profit growth, fueled by Stella Pack and strong margin expansion.SAR
H1 202422 Jan 2026 - Record sales and profit growth in 2024, with further gains and investments forecast for 2025.SAR
H2 202424 Dec 2025 - Profitability rose despite a slight sales dip, driven by margin expansion and US growth initiatives.SAR
Q3 2025 TU23 Oct 2025 - Net profit up 20% to €29.2m on 0.5% sales growth, led by Beauty, Skin & Sun Care.SAR
H1 202512 Sep 2025 - Net sales surged 27.9% to €452.0m, with margin gains and strong Stella Pack integration.SAR
Q3 2024 TU13 Jun 2025